{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:03:49Z","timestamp":1793394229241,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T00:00:00Z","timestamp":1549324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"RobertW. Storr Bequest to the University of Sydney Medical Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00109-019-01746-4","type":"journal-article","created":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T05:45:31Z","timestamp":1549345531000},"page":"423-434","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["AMPK agonist AICAR ameliorates portal hypertension and liver cirrhosis via NO pathway in the\u00a0BDL rat model"],"prefix":"10.1007","volume":"97","author":[{"given":"Liangshuo","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixia","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,5]]},"reference":[{"issue":"3","key":"1746_CR1","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jhep.2015.09.008","volume":"64","author":"R Dhanasekaran","year":"2016","unstructured":"Dhanasekaran R, Venkatesh SK, Torbenson MS, Roberts LR (2016) Clinical implications of basic research in hepatocellular carcinoma. J Hepatol 64(3):736\u2013745","journal-title":"J Hepatol"},{"key":"1746_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12916-014-0145-y","volume":"12","author":"AA Mokdad","year":"2014","unstructured":"Mokdad AA, Lopez AD, Shahraz S, Lozano R, Mokdad AH, Stanaway J, Murray CJ, Naghavi M (2014) Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med 12:145","journal-title":"BMC Med"},{"issue":"2","key":"1746_CR3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/gastro\/gox012","volume":"5","author":"B Procopet","year":"2017","unstructured":"Procopet B, Berzigotti A (2017) Diagnosis of cirrhosis and portal hypertension: imaging, non-invasive markers of fibrosis and liver biopsy. Gastroenterology report 5(2):79\u201389","journal-title":"Gastroenterology report"},{"key":"1746_CR4","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/liv.13589","volume":"38","author":"S Moller","year":"2017","unstructured":"Moller S, Bendtsen F (2017) The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis. Liver Int : official journal of the International Association for the Study of the Liver 38:570\u2013580","journal-title":"Liver Int : official journal of the International Association for the Study of the Liver"},{"issue":"7","key":"1746_CR5","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/jcbfm.2012.12","volume":"32","author":"NA Terpolilli","year":"2012","unstructured":"Terpolilli NA, Moskowitz MA, Plesnila N (2012) Nitric oxide: considerations for the treatment of ischemic stroke. J Cereb Blood Flow Metab : official journal of the International Society of Cerebral Blood Flow and Metabolism 32(7):1332\u20131346","journal-title":"J Cereb Blood Flow Metab : official journal of the International Society of Cerebral Blood Flow and Metabolism"},{"issue":"8","key":"1746_CR6","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.tips.2015.05.001","volume":"36","author":"Y Iwakiri","year":"2015","unstructured":"Iwakiri Y, Kim MY (2015) Nitric oxide in liver diseases. Trends Pharmacol Sci 36(8):524\u2013536","journal-title":"Trends Pharmacol Sci"},{"issue":"4","key":"1746_CR7","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1002\/hep.27343","volume":"61","author":"M Fernandez","year":"2015","unstructured":"Fernandez M (2015) Molecular pathophysiology of portal hypertension. Hepatology 61(4):1406\u20131415","journal-title":"Hepatology"},{"issue":"Pt 1","key":"1746_CR8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1113\/jphysiol.2006.108506","volume":"574","author":"B Viollet","year":"2006","unstructured":"Viollet B, Foretz M, Guigas B, Horman S, Dentin R, Bertrand L, Hue L, Andreelli F (2006) Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders. J Physiol 574(Pt 1):41\u201353","journal-title":"J Physiol"},{"issue":"11","key":"1746_CR9","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.3748\/wjg.v19.i11.1707","volume":"19","author":"LS Hu","year":"2013","unstructured":"Hu LS, George J, Wang JH (2013) Current concepts on the role of nitric oxide in portal hypertension. World J Gastroenterol 19(11):1707\u20131717","journal-title":"World J Gastroenterol"},{"issue":"2","key":"1746_CR10","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/hep.21991","volume":"47","author":"M Adachi","year":"2008","unstructured":"Adachi M, Brenner DA (2008) High molecular weight adiponectin inhibits proliferation of hepatic stellate cells via activation of adenosine monophosphate-activated protein kinase. Hepatology 47(2):677\u2013685","journal-title":"Hepatology"},{"issue":"9","key":"1746_CR11","doi-asserted-by":"publisher","first-page":"e106554","DOI":"10.1371\/journal.pone.0106554","volume":"9","author":"KH Chen","year":"2014","unstructured":"Chen KH, Hsu HH, Lee CC, Yen TH, Ko YC, Yang CW, Hung CC (2014) The AMPK agonist AICAR inhibits TGF-beta1 induced activation of kidney myofibroblasts. PLoS One 9(9):e106554","journal-title":"PLoS One"},{"key":"1746_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.yjmcc.2017.08.003","volume":"111","author":"KA Cieslik","year":"2017","unstructured":"Cieslik KA, Trial J, Entman ML (2017) Aicar treatment reduces interstitial fibrosis in aging mice: suppression of the inflammatory fibroblast. J Mol Cell Cardiol 111:81\u201385","journal-title":"J Mol Cell Cardiol"},{"issue":"4","key":"1746_CR13","doi-asserted-by":"publisher","first-page":"231","DOI":"10.4254\/wjh.v8.i4.231","volume":"8","author":"M Gjeorgjievski","year":"2016","unstructured":"Gjeorgjievski M, Cappell MS (2016) Portal hypertensive gastropathy: a systematic review of the pathophysiology, clinical presentation, natural history and therapy. World J Hepatol 8(4):231\u2013262","journal-title":"World J Hepatol"},{"issue":"1","key":"1746_CR14","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12916-017-0966-6","volume":"15","author":"A Berzigotti","year":"2017","unstructured":"Berzigotti A (2017) Advances and challenges in cirrhosis and portal hypertension. BMC Med 15(1):200","journal-title":"BMC Med"},{"issue":"3","key":"1746_CR15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.diff.2016.07.001","volume":"92","author":"D Karin","year":"2016","unstructured":"Karin D, Koyama Y, Brenner D, Kisseleva T (2016) The characteristics of activated portal fibroblasts\/myofibroblasts in liver fibrosis. Differentiation Res Biol Divers 92(3):84\u201392","journal-title":"Differentiation Res Biol Divers"},{"issue":"43","key":"1746_CR16","doi-asserted-by":"publisher","first-page":"7666","DOI":"10.3748\/wjg.v23.i43.7666","volume":"23","author":"Y Ni","year":"2017","unstructured":"Ni Y, Li JM, Liu MK, Zhang TT, Wang DP, Zhou WH, Hu LZ, Lv WL (2017) Pathological process of liver sinusoidal endothelial cells in liver diseases. World J Gastroenterol 23(43):7666\u20137677","journal-title":"World J Gastroenterol"},{"issue":"1 Suppl","key":"1746_CR17","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.1016\/j.jhep.2015.01.003","volume":"62","author":"J Bosch","year":"2015","unstructured":"Bosch J, Groszmann RJ, Shah VH (2015) Evolution in the understanding of the pathophysiological basis of portal hypertension: how changes in paradigm are leading to successful new treatments. J Hepatol 62(1 Suppl):S121\u2013S130","journal-title":"J Hepatol"},{"issue":"3","key":"1746_CR18","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1002\/hep.23421","volume":"51","author":"M Moreno","year":"2010","unstructured":"Moreno M, Gonzalo T, Kok RJ, Sancho-Bru P, van Beuge M, Swart J, Prakash J, Temming K, Fondevila C, Beljaars L, Lacombe M, van der Hoeven P, Arroyo V, Poelstra K, Brenner DA, Gines P, Bataller R (2010) Reduction of advanced liver fibrosis by short-term targeted delivery of an angiotensin receptor blocker to hepatic stellate cells in rats. Hepatology 51(3):942\u2013952","journal-title":"Hepatology"},{"issue":"3","key":"1746_CR19","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1124\/jpet.111.179143","volume":"337","author":"MM Beuge van","year":"2011","unstructured":"van Beuge MM, Prakash J, Lacombe M, Gosens R, Post E, Reker-Smit C, Beljaars L, Poelstra K (2011) Reduction of fibrogenesis by selective delivery of a Rho kinase inhibitor to hepatic stellate cells in mice. J Pharmacol Exp Ther 337(3):628\u2013635","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"1746_CR20","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1007\/s11095-011-0430-9","volume":"28","author":"MM Beuge van","year":"2011","unstructured":"van Beuge MM, Prakash J, Lacombe M, Post E, Reker-Smit C, Beljaars L, Poelstra K (2011) Increased liver uptake and reduced hepatic stellate cell activation with a cell-specific conjugate of the Rho-kinase inhibitor Y27632. Pharm Res 28(8):2045\u20132054","journal-title":"Pharm Res"},{"issue":"6","key":"1746_CR21","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.jhep.2012.07.033","volume":"57","author":"S Klein","year":"2012","unstructured":"Klein S, Van Beuge MM, Granzow M, Beljaars L, Schierwagen R, Kilic S, Heidari I, Huss S, Sauerbruch T, Poelstra K, Trebicka J (2012) HSC-specific inhibition of Rho-kinase reduces portal pressure in cirrhotic rats without major systemic effects. J Hepatol 57(6):1220\u20131227","journal-title":"J Hepatol"},{"issue":"2","key":"1746_CR22","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/hep.24395","volume":"54","author":"R Bansal","year":"2011","unstructured":"Bansal R, Prakash J, Post E, Beljaars L, Schuppan D, Poelstra K (2011) Novel engineered targeted interferon-gamma blocks hepatic fibrogenesis in mice. Hepatology 54(2):586\u2013596","journal-title":"Hepatology"},{"key":"1746_CR23","doi-asserted-by":"publisher","first-page":"136816","DOI":"10.4061\/2011\/136816","volume":"2011","author":"Y Haddad","year":"2011","unstructured":"Haddad Y, Vallerand D, Brault A, Spenard J, Haddad PS (2011) NCX 1000 alone or in combination with vitamin E reverses experimental nonalcoholic steatohepatitis in the rat similarly to UDCA. Int J Hepatol 2011:136816\u2013136812","journal-title":"Int J Hepatol"},{"issue":"2","key":"1746_CR24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1527-3466.2004.tb00136.x","volume":"22","author":"S Fiorucci","year":"2004","unstructured":"Fiorucci S, Antonelli E, Tocchetti P, Morelli A (2004) Treatment of portal hypertension with NCX-1000, a liver-specific NO donor. A review of its current status. Cardiovascular drug reviews 22(2):135\u2013146","journal-title":"Cardiovascular drug reviews"},{"issue":"3","key":"1746_CR25","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1478-3231.2008.01664.x","volume":"28","author":"E Biecker","year":"2008","unstructured":"Biecker E, Trebicka J, Kang A, Hennenberg M, Sauerbruch T, Heller J (2008) Treatment of bile duct-ligated rats with the nitric oxide synthase transcription enhancer AVE 9488 ameliorates portal hypertension. Liver Int : Official Journal of the International Association for the Study of the Liver 28(3):331\u2013338","journal-title":"Liver Int : Official Journal of the International Association for the Study of the Liver"},{"issue":"1","key":"1746_CR26","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/hep.21673","volume":"46","author":"J Trebicka","year":"2007","unstructured":"Trebicka J, Hennenberg M, Laleman W, Shelest N, Biecker E, Schepke M, Nevens F, Sauerbruch T, Heller J (2007) Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA\/Rho-kinase and activation of endothelial nitric oxide synthase. Hepatology 46(1):242\u2013253","journal-title":"Hepatology"},{"issue":"6","key":"1746_CR27","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1002\/hep.26939","volume":"59","author":"L Verbeke","year":"2014","unstructured":"Verbeke L, Farre R, Trebicka J, Komuta M, Roskams T, Klein S, Elst IV, Windmolders P, Vanuytsel T, Nevens F, Laleman W (2014) Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats. Hepatology 59(6):2286\u20132298","journal-title":"Hepatology"},{"issue":"3","key":"1746_CR28","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1053\/j.gastro.2003.12.007","volume":"126","author":"C Zafra","year":"2004","unstructured":"Zafra C, Abraldes JG, Turnes J, Berzigotti A, Fernandez M, Garca-Pagan JC, Rodes J, Bosch J (2004) Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis. Gastroenterology 126(3):749\u2013755","journal-title":"Gastroenterology"},{"issue":"6","key":"1746_CR29","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.jhep.2007.01.020","volume":"46","author":"JG Abraldes","year":"2007","unstructured":"Abraldes JG, Rodriguez-Vilarrupla A, Graupera M, Zafra C, Garcia-Caldero H, Garcia-Pagan JC, Bosch J (2007) Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic rats. J Hepatol 46(6):1040\u20131046","journal-title":"J Hepatol"},{"issue":"5","key":"1746_CR30","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1053\/j.gastro.2009.01.043","volume":"136","author":"JG Abraldes","year":"2009","unstructured":"Abraldes JG, Albillos A, Banares R, Turnes J, Gonzalez R, Garcia-Pagan JC, Bosch J (2009) Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial. Gastroenterology 136(5):1651\u20131658","journal-title":"Gastroenterology"},{"issue":"5","key":"1746_CR31","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1053\/j.gastro.2016.01.004","volume":"150","author":"JG Abraldes","year":"2016","unstructured":"Abraldes JG, Villanueva C, Aracil C, Turnes J, Hernandez-Guerra M, Genesca J, Rodriguez M, Castellote J, Garcia-Pagan JC, Torres F, Calleja JL, Albillos A, Bosch J, Group BS (2016) Addition of simvastatin to standard therapy for the prevention of variceal rebleeding does not reduce rebleeding but increases survival in patients with cirrhosis. Gastroenterology 150(5):1160\u20131170 e1163","journal-title":"Gastroenterology"},{"issue":"9","key":"1746_CR32","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1136\/gutjnl-2014-308338","volume":"64","author":"G Marrone","year":"2015","unstructured":"Marrone G, Maeso-Diaz R, Garcia-Cardena G, Abraldes JG, Garcia-Pagan JC, Bosch J, Gracia-Sancho J (2015) KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins. Gut 64(9):1434\u20131443","journal-title":"Gut"},{"issue":"22","key":"1746_CR33","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJM199105303242202","volume":"324","author":"T Poynard","year":"1991","unstructured":"Poynard T, Cales P, Pasta L, Ideo G, Pascal JP, Pagliaro L, Lebrec D (1991) Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group. N Engl J Med 324(22):1532\u20131538","journal-title":"N Engl J Med"},{"issue":"3","key":"1746_CR34","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1002\/hep.23045","volume":"50","author":"D Tripathi","year":"2009","unstructured":"Tripathi D, Ferguson JW, Kochar N, Leithead JA, Therapondos G, McAvoy NC, Stanley AJ, Forrest EH, Hislop WS, Mills PR, Hayes PC (2009) Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed. Hepatology 50(3):825\u2013833","journal-title":"Hepatology"},{"issue":"11","key":"1746_CR35","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1136\/gutjnl-2012-304038","volume":"62","author":"T Reiberger","year":"2013","unstructured":"Reiberger T, Ulbrich G, Ferlitsch A, Payer BA, Schwabl P, Pinter M, Heinisch BB, Trauner M, Kramer L, Peck-Radosavljevic M, Vienna Hepatic Hemodynamic L (2013) Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol. Gut 62(11):1634\u20131641","journal-title":"Gut"},{"key":"1746_CR36","doi-asserted-by":"publisher","first-page":"e1790","DOI":"10.1038\/cddis.2015.154","volume":"6","author":"X Tong","year":"2015","unstructured":"Tong X, Kono T, Evans-Molina C (2015) Nitric oxide stress and activation of AMP-activated protein kinase impair beta-cell sarcoendoplasmic reticulum calcium ATPase 2b activity and protein stability. Cell Death Dis 6:e1790","journal-title":"Cell Death Dis"},{"issue":"2","key":"1746_CR37","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.intimp.2015.02.018","volume":"25","author":"C Yang","year":"2015","unstructured":"Yang C, Gong X, Ai Q, Ge P, Lin L, Zhang L (2015) 5-Aminoimidazole-4-carboxamide-1-beta-d-ribofuranoside alleviated carbon tetrachloride-induced acute hepatitis in mice. Int Immunopharmacol 25(2):393\u2013399","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"1746_CR38","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10557-010-6277-1","volume":"25","author":"F Jia","year":"2011","unstructured":"Jia F, Wu C, Chen Z, Lu G (2011) AMP-activated protein kinase inhibits homocysteine-induced dysfunction and apoptosis in endothelial progenitor cells. Cardiovasc Drugs Ther 25(1):21\u201329","journal-title":"Cardiovasc Drugs Ther"},{"key":"1746_CR39","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.yjmcc.2015.07.010","volume":"86","author":"J Li","year":"2015","unstructured":"Li J, Wang Y, Wang Y, Wen X, Ma XN, Chen W, Huang F, Kou J, Qi LW, Liu B, Liu K (2015) Pharmacological activation of AMPK prevents Drp1-mediated mitochondrial fission and alleviates endoplasmic reticulum stress-associated endothelial dysfunction. J Mol Cell Cardiol 86:62\u201374","journal-title":"J Mol Cell Cardiol"},{"issue":"11","key":"1746_CR40","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1161\/01.RES.87.11.999","volume":"87","author":"M Oelze","year":"2000","unstructured":"Oelze M, Mollnau H, Hoffmann N, Warnholtz A, Bodenschatz M, Smolenski A, Walter U, Skatchkov M, Meinertz T, Munzel T (2000) Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide\/cGMP signaling and endothelial dysfunction. Circ Res 87(11):999\u20131005","journal-title":"Circ Res"},{"issue":"6","key":"1746_CR41","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.bcp.2008.11.027","volume":"77","author":"L Rivera","year":"2009","unstructured":"Rivera L, Moron R, Zarzuelo A, Galisteo M (2009) Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochem Pharmacol 77(6):1053\u20131063","journal-title":"Biochem Pharmacol"},{"issue":"9","key":"1746_CR42","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/hr.2014.90","volume":"37","author":"X Cao","year":"2014","unstructured":"Cao X, Luo T, Luo X, Tang Z (2014) Resveratrol prevents AngII-induced hypertension via AMPK activation and RhoA\/ROCK suppression in mice. Hypertens Res : Official Journal of the Japanese Society of Hypertension 37(9):803\u2013810","journal-title":"Hypertens Res : Official Journal of the Japanese Society of Hypertension"},{"issue":"11 Pt 1","key":"1746_CR43","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/S0895-7061(01)02220-8","volume":"14","author":"JS Petersen","year":"2001","unstructured":"Petersen JS, Andersen D, Muntzel MS, Diemer NH, Holstein-Rathlou NH (2001) Intracerebroventricular metformin attenuates salt-induced hypertension in spontaneously hypertensive rats. Am J Hypertens 14(11 Pt 1):1116\u20131122","journal-title":"Am J Hypertens"},{"issue":"5","key":"1746_CR44","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1161\/01.HYP.33.5.1135","volume":"33","author":"MS Muntzel","year":"1999","unstructured":"Muntzel MS, Hamidou I, Barrett S (1999) Metformin attenuates salt-induced hypertension in spontaneously hypertensive rats. Hypertension 33(5):1135\u20131140","journal-title":"Hypertension"},{"issue":"3","key":"1746_CR45","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/aps.2017.120","volume":"39","author":"C Li","year":"2018","unstructured":"Li C, Jiang F, Li YL, Jiang YH, Yang WQ, Sheng J, Xu WJ, Zhu QJ (2018) Rhynchophylla total alkaloid rescues autophagy, decreases oxidative stress and improves endothelial vasodilation in spontaneous hypertensive rats. Acta Pharmacol Sin 39(3):345\u2013356","journal-title":"Acta Pharmacol Sin"},{"issue":"6","key":"1746_CR46","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1161\/ATVBAHA.110.204404","volume":"30","author":"EA Bradley","year":"2010","unstructured":"Bradley EA, Eringa EC, Stehouwer CD, Korstjens I, van Nieuw Amerongen GP, Musters R, Sipkema P, Clark MG, Rattigan S (2010) Activation of AMP-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside in the muscle microcirculation increases nitric oxide synthesis and microvascular perfusion. Arterioscler Thromb Vasc Biol 30(6):1137\u20131142","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"1746_CR47","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1478-3231.2008.01909.x","volume":"29","author":"MS Mohammadi","year":"2009","unstructured":"Mohammadi MS, Thabut D, Cazals-Hatem D, Galbois A, Rudler M, Bonnefont-Rousselot D, Moreau R, Lebrec D, Tazi KA (2009) Possible mechanisms involved in the discrepancy of hepatic and aortic endothelial nitric oxide synthases during the development of cirrhosis in rats. Liver Int : Official Journal of the International Association for the Study of the Liver 29(5):692\u2013700","journal-title":"Liver Int : Official Journal of the International Association for the Study of the Liver"},{"issue":"1","key":"1746_CR48","doi-asserted-by":"publisher","first-page":"9372","DOI":"10.1038\/s41598-018-27656-y","volume":"8","author":"P Schwabl","year":"2018","unstructured":"Schwabl P, Brusilovskaya K, Supper P, Bauer D, Konigshofer P, Riedl F, Hayden H, Fuchs CD, Stift J, Oberhuber G, Aschauer S, Bonderman D, Gnad T, Pfeifer A, Uschner FE, Trebicka J, Rohr-Udilova N, Podesser BK, Peck-Radosavljevic M, Trauner M, Reiberger T (2018) The soluble guanylate cyclase stimulator riociguat reduces fibrogenesis and portal pressure in cirrhotic rats. Sci Rep 8(1):9372","journal-title":"Sci Rep"},{"issue":"10","key":"1746_CR49","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.3109\/10715762.2015.1067806","volume":"49","author":"Y Chen","year":"2015","unstructured":"Chen Y, Qing W, Sun M, Lv L, Guo D, Jiang Y (2015) Melatonin protects hepatocytes against bile acid-induced mitochondrial oxidative stress via the AMPK-SIRT3-SOD2 pathway. Free Radic Res 49(10):1275\u20131284","journal-title":"Free Radic Res"},{"issue":"3","key":"1746_CR50","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/jgh.12723","volume":"30","author":"Y Yang","year":"2015","unstructured":"Yang Y, Zhao Z, Liu Y, Kang X, Zhang H, Meng M (2015) Suppression of oxidative stress and improvement of liver functions in mice by ursolic acid via LKB1-AMP-activated protein kinase signaling. J Gastroenterol Hepatol 30(3):609\u2013618","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-019-01746-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-019-01746-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-019-01746-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T00:21:40Z","timestamp":1580862100000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-019-01746-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,5]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["1746"],"URL":"https:\/\/doi.org\/10.1007\/s00109-019-01746-4","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,5]]},"assertion":[{"value":"1 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}